25 Nov
While the staff of the Multiple Sclerosis Centre has reached amazing heights in its research with the results being published in the most prestigious neurological journals in the world, they have been working in a unit whose physical appearance and arrangement are years behind. Now thanks to a generous donation by Hadassah UK, this unit […]
READ MORE17 Dec
A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof. […]
READ MORE10 Dec
Breaking news: The results of the latest M.S. research project study at Hadassah Hospitals in Jerusalem are just published in “Brain” Journal of Neurology by Oxford Academic. Hadassah UK is proud to have supported Multiple Sclerosis research at Hadassah by a team led by Prof. Dimitrios Karussis. Prof. Karussis’ team study is a culmination of […]
READ MORE11 Mar
Written by Sarit Kleiman Synopsis Three weeks after the birth of their son, Arie Biton was diagnosed with M.S. A pioneering limited clinical trial for Israeli qualifying patients, using stem cells in Hadassah Ein Kerem is led by Prof. Dimitrios Karussis. This could help find a MS treatment and is missing $1 million. Sarit Kleiman […]
READ MOREHadassah UK © 2022 | w/creators with Web Studio Lab
Join our digital newsletter to stay in touch with the latest news from Hadassah UK